Syneos Health to acquire Synteract
With the purchase, Syneos Health seeks to strengthen connections with the rapidly growing pre-revenue biopharmaceutical market, and expand global reach.
With the purchase, Syneos Health seeks to strengthen connections with the rapidly growing pre-revenue biopharmaceutical market, and expand global reach.
A leader from the STA Pharmaceutical subsidiary of WuXI AppTec talks about the dynamic HPAPI market and what’s ahead for their operation.
A new movement is working to bring leaders together from all corners of clinical research for to work toward the continued success of the industry.